Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-25 @ 9:23 PM
Study NCT ID:
NCT03207256
Status:
TERMINATED
Last Update Posted:
2022-07-21
First Post:
2017-06-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Extension Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials
Sponsor:
TG Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-28
First Submit QC Date:
None
Study First Post Date:
2017-07-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-20
Last Update Post Date:
2022-07-21
Last Update Post Date Type:
ACTUAL